ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
S&P ASX 20 Index

S&P ASX 20 Index (XTL)

4,652.90
35.60
(0.77%)
Closed September 19 2:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4,652.90
Price Change
35.60
Change %
0.77%
Name
S&P ASX 20 Index
Symbol
XTL
4,617.30 Day's Range 4,659.80
0.00 52 Week Range 0.00
Bid
0.00
Ask
0.00
Open
4,617.30
High
4,659.80
Low
4,617.30
Close
4,652.90
Previous Close
4,617.30
Market
Australian Stock Exchange
Type
Index

XTL Latest News

XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives

VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLBNASDAQ:TASE:NASDAQ:XTL) today announced an update to its December 8, 2008 press release regarding...

XTLbio Announces Grant of hMAb Patent

XTLbio Announces Grant of Human Monoclonal Antibody Patent Patent Covers Antibodies Directed Against Hepatitis B Virus Surface Antigen Rehovot, Israel 26 January 2004 - XTL Biopharmaceuticals...

XTLbio appoints Stockbroker and Financial Adviser

XTLbio appoints Stockbroker and Financial Adviser Rehovot, 20 January 2004 - The Board of XTL Biopharmaceuticals Ltd ("XTLbio" or the "Company") is pleased to announce the appointment of Code...

XTLbio announces appointment of Non-Executive Director

XTLbio announces appointment of Non-Executive Director Rehovot, 12 January 2004 - XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the appointment of Peter Stalker, III, as a...

Business Update

RNS Number:2908T XTL Biopharmaceuticals Limited 16 December 2003 XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today...

XTLbio R&D and Business Development Update

XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today announces an update on recent clinical progress and corporate developments...

XTLbio Highlights Presence at The Liver Meeting

XTLbio Highlights Presence at The Liver Meeting HepeX Programs at 54th Annual AASLD include Poster Presentations, Oral Presentation and Exhibitors Booth Rehovot, Israel, 28 October 2003: XTL...

Directorate Change

XTLbio announces appointment of Non-Executive Director Rehovot, Israel, 20 October 2003: XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the appointment of Dr. Hadar Ron as a...

Holding(s) in Company

NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company XTL Biopharmaceuticals Limited 2) Name of shareholder having a major interest Perpetual Income & Growth Investment Trust plc 3) Please...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000IX
40000000IX
120000000IX
260000000IX
520000000IX
1560000000IX
2600000000IX
Indices
Commodities
Forex
US5005,614.000.000.00%
US3041,619.000.000.00%
US1002,700.400.000.00%
DJI41,503.10-103.08-0.25%
SP5005,618.26-16.32-0.29%
COMPX17,573.30-54.76-0.31%
DXY100.414-0.196-0.19%

Your Recent History

Delayed Upgrade Clock